M
Massimo Colombo
Researcher at Humanitas University
Publications - 504
Citations - 43496
Massimo Colombo is an academic researcher from Humanitas University. The author has contributed to research in topics: Hepatitis C & Hepatocellular carcinoma. The author has an hindex of 90, co-authored 483 publications receiving 39369 citations. Previous affiliations of Massimo Colombo include University of Milan & Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Papers
More filters
Journal ArticleDOI
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Jordi Bruix,Morris Sherman,Josep M. Llovet,Michel Beaugrand,Riccardo Lencioni,Andrew K. Burroughs,Erik Christensen,Luigi Pagliaro,Massimo Colombo,Juan Rodés +9 more
Journal ArticleDOI
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
George Kuo,Q L Choo,Harvey J. Alter,G.L. Gitnick,Allan G. Redeker,Robert H. Purcell,Tatsuo Miyamura,Jules L. Dienstag,M.J. Alter,Cladd E. Stevens,Gary E. Tegtmeier,Ferruccio Bonino,Massimo Colombo,W.-S. Lee,C. Kuo,K. Berger,Jeffrey R. Shuster,Lacy Rasco Overby,Daniel W. Bradley,Michael Houghton +19 more
TL;DR: Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses.
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer
Josep M. Llovet,Michel Ducreux,Riccardo Lencioni,Adrian M. Di Bisceglie,Jean-Francois J. DuFour,Tim F. Greten,Eric Raymond,Tania Roskams,Vincenzo Mazzaferro,Jordi Bruix,Massimo Colombo,Andrew X. Zhu +11 more
TL;DR: The purpose of this document is to assist physicians, patients, health-care providers, and health-policy makers from Europe and worldwide in the decision-making process according to evidencebased data.
Journal ArticleDOI
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
Daniele Prati,Emanuela Taioli,Alberto Zanella,Emanuela Della Torre,Sonia Butelli,Emanuela Del Vecchio,Luciana Vianello,F. Zanuso,F. Mozzi,Silvano Milani,Dario Conte,Massimo Colombo,Girolamo Sirchia +12 more
TL;DR: This study redefined ALT limits in blood donors at low risk for NAFLD and without hepatitis B or C and tested the sensitivity and specificity of the ranges obtained from these participants in the clinical evaluation of anti-HCVpositive persons with and without chronic liver damage.
Journal ArticleDOI
Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies
Felice Piccinino,Evangelista Sagnelli,Giuseppe Pasquale,Giusti G,A. Battocchia,Mauro Bernardi,R. Bertolazzi,F.B. Bianchi,E. Brunelli,Gabriele Budillon,L. Buscarini,A. Cargnel,G. Carrara,N. Carulli,L. Caruso,V. Cataldi,G. Celle,L. Chiandussi,L. Chiesa,Massimo Colombo,M. Coltorti,C. De Bac,C. Del Vecchio Blanco,G. Di Marco,F. Fiaccadori,M.G. Filippazzo,F. Fornari,A. Francavilla,M. Frezza,V. Gallo,V. Galvani,T. Givatto,C. Iannuzzi,Izzo Cm,S. Le Moli,G. Longo,G. Magnani,M. Manai,F. Manenti,Onofrio Giuseppe Manghisi,Manzillo G,G. Marenco,F. Miglio,G. Molino,P.G. Mosca,R. Moschetta,C. Panella,G. Panichi,G. Parrilli,G. Pastore,C. Peluso,A. Picciotto,G. Pilleri,E. Pisi,M. Ponz de Leon,M. Rago,G. Raimondo,G. Realdi,M. Rizzetto,A. Rizzo,G. Ronchi,F. Rossi Fanelli,Giuseppe Ruggiero,N. Russo,A. Satta,D.E. Sansonno,C. Struglia,P. Tolentino,F. Tremolada,C. Trischitta,G. Verme,P. Viganò,G. Visco,P. Zivelonghi +73 more
TL;DR: In this paper, the complications that arose after percutaneous liver biopsies performed from 1973 to 1983 were analyzed in relation to the underlying liver disease and to the type of needle used.